REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medisin Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medisin Sas Profile Updated: May 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Medisin Sas is based in Colombia. The head office is in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 15, 2013. 97 (2025) employees currently work for Medisin Sas. The company’s latest financial report indicates a net sales revenue increase of 12.13% in 2024. Its’ total assets recorded a growth of 15.95%. In 2024, Medisin Sas’s net profit margin decreased by 0.83%.

Headquarters
Calle 48 # 22 - 22
Bucaramanga; Santander;

Contact Details: Purchase the Medisin Sas report to view the information.

Basic Information
Total Employees:
Purchase the Medisin Sas report to view the information.
Registered Capital:
Purchase the Medisin Sas report to view the information.
Financial Auditors:
Purchase the Medisin Sas report to view the information.
Incorporation Date:
January 15, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Medisin Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
12.13%▲
Total operating revenue
11.97%▲
Operating profit (EBIT)
-11.71%▼
EBITDA
-11.58%▼
Net Profit (Loss) for the Period
-3.75%▼
Total assets
15.95%▲
Total equity
20.7%▲
Operating Profit Margin (ROS)
-3.18%▼
Net Profit Margin
-0.83%▼
Return on Equity (ROE)
-4.36%▼
Debt to Equity Ratio
-23.77%▼
Quick Ratio
0.3%▲
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo